arrow
M

María E. Figueroa

university of miami
H指数:59
被引数:2.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Retinoic acid and ascorbate synergize to suppress myeloid leukemia via TET2 activation

视黄酸和抗坏血酸通过TET2激活协同抑制髓系白血病

2025-10-010
OAAI
XPO1 Drives Resistance to Eprenetapopt and Azacitidine and Can Be Targeted in TP53 Mutated Myeloid Malignancies

XPO1驱动对Eprenetapopt和Azacitidine的抵抗,并且可以在TP53突变的髓系恶性疾病中作为靶点

Blood
IF23.1
2025-08-050
PRE
Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/SyndromesdRecommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS])

骨髓增生异常肿瘤/综合征的诊断和分类的当代方法国际骨髓增生异常肿瘤/综合征联合会 (MDS [icMDS]) 的建议

2024-12-011
PRE
EPIGENETIC POTENTIATION OF ANTI-TUMOR IMMUNE RESPONSES USING VIRAL MIMICRY IN GLIOMAS
2024-11-110
PRE
Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS)

骨髓增生异常综合征/肿瘤 (MDS) 的分类,风险分层和反应评估: 代表国际MDS联合会 (icMDS) 的最新报告

2023-11-019
OAAI
Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1st International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)

骨髓增生异常综合征/肿瘤 (MDS) 的转化和临床研究现状: 国际MDS联合会 (icMDS) 第一届国际MDS研讨会 (iwMDS) 的论文集

2023-07-018
PRE
An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS

推进骨髓增生异常综合征研究的议程: 第一届MDS国际研讨会的十大优先事项清单

2023-06-146
OAAI
Oxidized mC modulates synthetic lethality to PARP inhibitors for the treatment of leukemia
2023-01-015
OAAI
Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes
LEUKEMIA
IF13.4
2022-10-2016
PRE
Macrophage migration inhibitory factor is overproduced through EGR1 in TET2low resting monocytes
2022-02-0317
OAAI